261
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Predicting key drivers for health care expenditure growth in the Middle East region: a Grossman-PLS modeling approach

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 1021-1031 | Received 10 May 2021, Accepted 29 Apr 2022, Published online: 16 May 2022

References

  • World development indicators | databank 12 January 2021. https://databank.worldbank.org/source/world-development-indicators.
  • Barkat K, Sbia R, Maouchi Y. Empirical evidence on the long and short-run determinants of health expenditure in the Arab world. Q Rev Econ Finance. 2019;73:78–87.
  • Ventelou B, Abu-Zaineh M. Medicine, and Democracy: the importance of institutional quality in the relationship between health expenditure and health outcomes in the MENA region. Health Policy. 2016;1208:928–935.
  • Roberts J. Sensitivity of elasticity estimates for OECD health care spending: analysis of a dynamic heterogeneous data field. Health Econ. 1999;85:459–472.
  • Gerdtham UG, Jönsson B. International comparisons of health expenditure: theory, data, and econometric analysis. Handb Health Econ. 2000;1:11–53.
  • Grossman M. On the concept of health capital and the demand for health. J Polit Econ. 1972;802:223–255.
  • Hartwig J, Sturm JE. Testing the Grossman model of medical spending determinants with macroeconomic panel data. Eur J Health Econ. 2018;198:1067–1086.
  • Becker GS. . Concise Encycl Econ. 2002 228- 294 28 March 2012;2 (Chicago and London: The University of Chicago Press).
  • Wagstaff A. The demand for health: some new empirical evidence. J Health Econ. 1986;53:195–233.
  • Wagstaff A. The demand for health: an empirical reformulation of the Grossman model. Health Econ. 1993;22:189–198.
  • Zweifel P. The Grossman model after 40 years. Eur J Health Econ. 2012;136:677–682.
  • Grossman M. The human capital model. Handb Health Econ. 2000;1:347–408.
  • Balkhi B, Alshayban D, Alotaibi NM. Impact of healthcare expenditures on healthcare outcomes in the Middle East and North Africa (MENA) Region: a cross-country comparison, 1995–2015. Front Public Health. 2021;8. DOI:10.3389/fpubh.2020.624962
  • Zhou L, Ampon-Wireko, S, Antwi, HA et al. An empirical study on the determinants of health care expenses in emerging economies. BMC Health Serv Res. 2020;201:1–16.
  • Yetim B, İlgün G, Çilhoroz Y, et al. The socioeconomic determinants of health expenditure in OECD: an examination on panel data. Int J Healthc Manag. 2020;7:1–5.
  • Cheah YK, Goh KL, Adzis AA. Sociodemographic determinants of health care expenditure: micro-level evidence of a fast-growing developing country. Int J Soc Econ. 2021;484:640–666.
  • Cheung EC, Ma YC. Long-term determinants of healthcare expenditure in Hong Kong. In: Modeling Economic Growth in Contemporary Hong Kong. Emerald Publishing Limited; 2021.
  • Erbsland M, Ried W, Ulrich V. Health, health care, and the environment-Econometric evidence from German micro data. Health Econ. 1995;43:169–182.
  • Jakovljevic M, Sugahara T, Timofeyev Y, et al. Predictors of (in)efficiencies of healthcare expenditure among the leading Asian Economies – comparison of OECD and Non-OECD Nations. Risk Manag Healthc Policy. 2020;13:2261–2280.
  • Jakovljevic M, Timofeyev Y, Ranabhat CL, et al. Real GDP growth rates, and healthcare spending – comparison between the G7 and the EM7 countries. Glob Health. 2020;161:1–13.
  • Salminen A, Hyttinen JM, Kaarniranta K. AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (Berl). 2011;897:667–676.
  • Seeman TE, Crimmins E, Huang M-H, et al. Cumulative biological risk and socio-economic differences in mortality: MacArthur studies of successful aging. Soc Sci Med. 2004;89(10):667–676.
  • Engchuan W, Dimopoulos AC, Tyrovolas S, et al. Sociodemographic indicators of health status using a machine learning approach and data from the English longitudinal study of aging (ELSA). Med Sci Monitor. 2019;25:1994.
  • Spinks J, Hollingsworth B. Cross-country comparisons of technical efficiency of health production: a demonstration of pitfalls. Appl Econ. 2009;414:417–427.
  • Hitiris T. Health care expenditure and integration in the countries of the European Union. Appl Econ. 1997;291:1–6.
  • Winkelmann J, Muench U, Maier CB. Time trends in the regional distribution of physicians, nurses, and midwives in Europe. BMC Health Serv Res. 2020;201:1–15.
  • Okunade AA, Murthy VN. Technology as a ‘major driver’of health care costs: a cointegration analysis of the Newhouse conjecture. J Health Econ. 2002;211:147–159.
  • Khan JR, Awan N, Islam M, et al. Healthcare capacity, health expenditure, and civil society as predictors of COVID-19 case fatalities: a global analysis. Front Public Health. 2020;8:347.
  • Mean years of schooling. Our World in Data 15 January 2021. https://ourworldindata.org/grapher/mean-years-of-schooling-1.
  • Arnold J, Bassanini A, Scarpetta S. “Solow or Lucas? Testing speed of convergence on a panel of OECD countries. Res. Econ. 2011;652:110–123.
  • Hoechle D. Robust standard errors for panel regressions with cross-sectional dependence. Stata J. 2007;73:281–312.
  • Anderson JC, Gerbing DW. Structural equation modeling in practice: a review and recommended two-step approach. Psychol Bull. 1998;1033:411–423.
  • Hair JF, Anderson RE, Tatham RL, et al. Multivariate data analysis. Englewood Cliff N J USA. 1998;53:207–219.
  • Nunnally JC. The assessment of reliability. Psychometric Theory. 1994;3:248–292.
  • Hair JF, Sarstedt M, Matthews LM, et al. Identifying and treating unobserved heterogeneity with FIMIX-PLS: part I–method. Eur Bus Rev. 2016;28:63–76.
  • Golob TF. Structural equation modeling for travel behavior research. Transp. Res. Part B Methodol. 2003;371:1–25.
  • Henseler J, Ringle CM, Sinkovics RR. The use of partial least squares path modeling in international marketing. In: New challenges to international marketing. Bingley, West Yorkshire, England: Emerald Group Publishing Limited; 2009.
  • Hair JF, Sarstedt M, Ringle CM, et al. An assessment of the use of partial least squares structural equation modeling in marketing research. J Acad Mark Sci. 2012;403:414–433.
  • Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. J Mark Res. 1981;181:39–50.
  • Chin WW. The partial least squares approach to structural equation modeling. Mod Methods Bus Res. 1998;2952:295–336.
  • Geisser S. The predictive sample reuse method with applications. J Am Stat Assoc. 1975;70350:320–328.
  • Stone M. An asymptotic equivalence of choice of model by cross‐validation and Akaike’s criterion. J R Stat Soc Ser B Methodol. 1977;391:44–47.
  • Nocera S, Zweifel P. The demand for health: an empirical test of the Grossman model using panel data. In: Health, the medical profession, and regulation. Vol. 6 (Salmon Tower Building New York City: Springer). 1998. p. 35–49.
  • Hartwig J, Sturm JE. Robust determinants of health care expenditure growth. Appl Econ. 2014;4636:4455–4474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.